Meyer, Guy <br/><br/>
Fibrinolysis for patients with intermediate-risk pulmonary embolism.  [electronic resource] 

 -  The New England journal of medicine  Apr 2014 
 - 1402-11 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1302097  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Fibrinolytic Agents--adverse effects<br/>Hemorrhage--chemically induced<br/>Heparin--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Pulmonary Embolism--complications<br/>Risk Factors<br/>Stroke--chemically induced<br/>Tenecteplase<br/>Tissue Plasminogen Activator--adverse effects<br/>Treatment Outcome<br/>Troponin--blood<br/>Ventricular Dysfunction, Right--etiology